Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) has emerged as an acquired immune‐mediated demyelinating disorder of the central nervous system distinct from multiple sclerosis (MS). This evidence concerns the gene MOG and nervousness.